Reviva Pharmaceuticals Holdings (RVPH) Times Interest Earned (2023 - 2026)
Reviva Pharmaceuticals Holdings (RVPH) posted Times Interest Earned of -$491.8 for Q1 2026, down 177.66% sequentially from $633.28 in Q4 2025, and up 12.59% YoY from -$436.79 in Q1 2025.
Reviva Pharmaceuticals Holdings (RVPH) Times Interest Earned (2023 - 2026) Analysis & Trends
Reviva Pharmaceuticals Holdings has reported Times Interest Earned for 4 years, with the latest figure at -$491.8 in Q1 2026.
- Quarterly Times Interest Earned rose 12.59% year-over-year to -$491.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2007.6 (down 116.3% YoY) and the FY2025 annual result came in at -$0.57, up 41.54% from the prior year.
- Times Interest Earned fell to -$491.8 in Q1 2026 per RVPH's latest filing, from $633.28 in the prior quarter.
- Over five years, Times Interest Earned peaked at $633.28 in Q4 2025 and troughed at -$1577.7 in Q2 2024.
- A 4-year average of -$662.03 and a median of -$562.66 in 2025 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned tumbled 4276.65% in 2024, then surged 147.47% in 2025.
- Over 4 years, Times Interest Earned stood at -$942.33 in 2023, then tumbled by 41.57% to -$1334.0 in 2024, then soared by 147.47% to $633.28 in 2025, then slumped by 177.66% to -$491.8 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$491.8, $633.28, and -$1547.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Reviva Pharmaceuticals Holdings | 6.74 Mn | 6.74 Mn | - | -891.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -891.84 |
| Mar 31, 2026 | -491.80 |
| Dec 31, 2025 | 633.28 |
| Sep 30, 2025 | -1,546.96 |
| Jun 30, 2025 | -1,266.00 |
| Mar 31, 2025 | -562.66 |
| Dec 31, 2024 | -1,334.03 |
| Sep 30, 2024 | -101.32 |
| Jun 30, 2024 | -1,577.65 |
| Mar 31, 2024 | -431.72 |
| Dec 31, 2023 | -942.33 |
| Sep 30, 2023 | -36.77 |
| Jun 30, 2023 | -36.05 |
| Mar 31, 2023 | -912.44 |